Difficulty: Medium
Average Score: 64%
Practice
The drug that is LEAST effective for the treatment of chronic renal disease occurring in 1-2% of children with Henoch-Schonlein purpura (HSP) is
Correct answer
A
Rationale
In the context of pediatric nursing and the treatment of chronic renal disease in children with Henoch-Schonlein purpura (HSP), the correct answer is A) prednisolone. Prednisolone is the least effective in this scenario because it is a corticosteroid used primarily for its anti-inflammatory properties. In chronic renal disease associated with HSP, the main treatment goal is to manage inflammation and prevent renal damage. Prednisolone alone may not adequately address the underlying renal pathology in these cases.
Option B) azathioprine is an immunosuppressant that can be used in chronic renal disease to dampen the immune response and reduce inflammation. It is often considered in cases where corticosteroids alone are not sufficient.
Option C) cyclophosphamide is a potent immunosuppressant used in severe cases of autoimmune diseases to suppress the immune system's activity. While it can be effective in certain conditions, it comes with significant side effects and is typically reserved for more aggressive disease processes.
Option D) cyclosporine is another immunosuppressant that is sometimes used in renal diseases to modulate the immune response. It is not the least effective in this context but may have more potential side effects compared to other options.
Educationally, understanding the rationale behind the choice of medication in pediatric patients with chronic renal disease associated with HSP is crucial for nursing practice. It is essential to consider the mechanism of action, potential side effects, and overall effectiveness of each medication to provide safe and evidence-based care to these vulnerable patients.
Option B) azathioprine is an immunosuppressant that can be used in chronic renal disease to dampen the immune response and reduce inflammation. It is often considered in cases where corticosteroids alone are not sufficient.
Option C) cyclophosphamide is a potent immunosuppressant used in severe cases of autoimmune diseases to suppress the immune system's activity. While it can be effective in certain conditions, it comes with significant side effects and is typically reserved for more aggressive disease processes.
Option D) cyclosporine is another immunosuppressant that is sometimes used in renal diseases to modulate the immune response. It is not the least effective in this context but may have more potential side effects compared to other options.
Educationally, understanding the rationale behind the choice of medication in pediatric patients with chronic renal disease associated with HSP is crucial for nursing practice. It is essential to consider the mechanism of action, potential side effects, and overall effectiveness of each medication to provide safe and evidence-based care to these vulnerable patients.